Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Is Ocugen's Surge Much Ado About Nothing?

TheMotleyFool

0 0

Is Ocugen's Surge Much Ado About Nothing?

Ocugen (NASDAQ: OCGN) stock enjoyed a big run-up as investors awaited a decision by the World Health Organization (WHO) on Emergency Use Listing (EUL) for COVID-19 vaccine Covaxin. In this Motley Fool Live video recorded on Oct. 27, Motley Fool contributors Keith Speights and Brian Orelli discuss whether or not Ocugen's recent surge is much ado about nothing.

Source Fool.com

Like: 0

OCGN

Share